Circulating markers of bone turnover

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

(2016) Stuart M. Sprague et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

(2016) Natalia Carrillo-López et al.   KIDNEY INTERNATIONAL

Parathyroid hormone metabolism and signaling in health and chronic kidney disease

(2016) Pieter Evenepoel et al.   KIDNEY INTERNATIONAL

Bone Alkaline Phosphatase Isoforms in Hemodialysis Patients With Low Versus Non-Low Bone Turnover: A Diagnostic Test Study

(2015) Mathias Haarhaus et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism

(2015) Geert J. Behets et al.   KIDNEY INTERNATIONAL

Sclerostin in Institutionalized Elderly Women: Associations with Quantitative Bone Ultrasound, Bone Turnover, Fractures, and Mortality

(2014) Karin Amrein et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis

(2014) Y. Nagata et al.   OSTEOPOROSIS INTERNATIONAL

Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand

(2014) YUANDONG LV et al.   Experimental and Therapeutic Medicine

The clinical utility of bone marker measurements in osteoporosis

(2013) Gillian Wheater et al.   Journal of Translational Medicine

Calcifying Human Aortic Smooth Muscle Cells Express Different Bone Alkaline Phosphatase Isoforms, Including the Novel B1x Isoform

(2013) Mathias Haarhaus et al.   JOURNAL OF VASCULAR RESEARCH

Indoxyl sulfate promotes apoptosis in cultured osteoblast cells

(2013) Young-Hee Kim et al.   BMC Pharmacology & Toxicology

Impact of Inflammation on the Osteoblast in Rheumatic Diseases

(2013) Rebecca Baum et al.   Current Osteoporosis Reports

Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: Is it so simple?

(2012) Pierre Delanaye et al.   CLINICA CHIMICA ACTA

The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis

(2012) Shunsuke Yamada et al.   CLINICAL ENDOCRINOLOGY

Physical Activity in Relation to Serum Sclerostin, Insulin-Like Growth Factor-1, and Bone Turnover Markers in Healthy Premenopausal Women: A Cross-Sectional and a Longitudinal Study

(2012) Mohammed-Salleh M. Ardawi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone Alkaline Phosphatase and Mortality in Dialysis Patients

(2011) C. Drechsler et al.   Clinical Journal of the American Society of Nephrology

Mineral Metabolism Markers and the Long-Term Risk of Hip Fracture: The Cardiovascular Health Study

(2011) Cassianne Robinson-Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells

(2011) Dongxing Zhu et al.   PLoS One

Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients

(2010) Hartmut H Malluche et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Calcemic Response to Continuous Parathyroid Hormone (PTH)(1-34) Infusion in End-Stage Kidney Disease Varies According to Bone Turnover: A Potential Role for PTH(7-84)

(2010) Katherine Wesseling-Perry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relationship between Bone Histology and Markers of Bone and Mineral Metabolism in African-American Hemodialysis Patients

(2009) C. Moore et al.   Clinical Journal of the American Society of Nephrology

Assessing the Clinical Utility of Serum CTX in Postmenopausal Osteoporosis and Its Use in Predicting Risk of Osteonecrosis of the Jaw

(2009) Sanford Baim et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Levels of TRAP5b, a New Bone Resorption Marker Unaffected by Renal Dysfunction, as a Useful Marker of Cortical Bone Loss in Hemodialysis Patients

(2008) Kaori Shidara et al.   CALCIFIED TISSUE INTERNATIONAL

Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction

(2008) Shinsuke Yamada et al.   CLINICAL ENDOCRINOLOGY

Histomorphometric Measurements of Bone Turnover, Mineralization, and Volume

(2008) S. M. Ott   Clinical Journal of the American Society of Nephrology